Top compounds associated with response to CRK


Feature Type Standardized
Nominal ANOVA
mRNA THZ-2-49 GDSC1000 pan-cancer AAC 0.063 0.07
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.079 0.07
mRNA Merck60 CTRPv2 pan-cancer AAC -0.065 0.07
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.067 0.07
mRNA TL-2-105 GDSC1000 pan-cancer AAC -0.068 0.07
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC 0.079 0.08
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.08
mRNA Epothilone B GDSC1000 pan-cancer AAC 0.072 0.08
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.078 0.08
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.08
Download CSV